Lepsien G, Sonnenberg A, Berges W, Weber K B, Wienbeck M, Siewert J R, Blum A L
Dtsch Med Wochenschr. 1979 Jun 22;104(25):901-6. doi: 10.1055/s-0028-1104011.
The effect of cimetidine on reflux oesophagitis was studied in a double-blind trial. Sixteen patients were given cimetidine 1.6 g/d, 20 patients received a placebo. Within the first six weeks the oesophagitis improved both on cimetidine and the placebo, but the patients taking the former had fewer complaints during the day than those on a placebo. Continuing the regimen for another six weeks further improved the endoscopic findings in patients with cimetidine but not in those on placebos. Complaints lessened during the sixth to twelfth week during cimetidine treatment, but remained unchanged under placebo administration. Complete healing of the oesophagitis was achieved in only 33% of patients with uncomplicated oesophagitis (grade I-III) and in 6% of those with severe complicated oesophagitis (grade IV). If non-surgical treatment is indicated, it must be continued through at least 6-12 weeks.
在一项双盲试验中研究了西咪替丁对反流性食管炎的疗效。16名患者服用西咪替丁1.6g/天,20名患者接受安慰剂治疗。在前六周内,服用西咪替丁和安慰剂的患者食管炎均有改善,但服用前者的患者白天的不适症状比服用安慰剂的患者少。将该治疗方案再持续六周,服用西咪替丁的患者内镜检查结果进一步改善,而服用安慰剂的患者则无改善。在西咪替丁治疗的第六至十二周期间,不适症状减轻,但在服用安慰剂期间保持不变。单纯性食管炎(I - III级)患者中只有33%实现食管炎完全愈合,重度复杂性食管炎(IV级)患者中这一比例为6%。如果需要进行非手术治疗,则必须持续至少6 - 12周。